Hartig Drug to Begin Administering Pfizer Covid-19 Vaccine Booster Shots

DUBUQUE, Iowa – Beginning today, Hartig Drug Company locations will administer booster doses of Pfizer-BioNTech Covid-19 vaccine to individuals based on the Centers for Disease Control and Prevention (CDC) recommendations below:  

1. People 65 years and older, residents in long-term care settings, and people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series; and
2. Health care workers, people aged 18–49 years with underlying medical conditions, and others who are at increased risk for COVID-19 exposure and transmission because of occupation may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.

Hartig Drug's announcement follows the CDC recommendation endorsing the use of a booster dose of Pfizer-BioNTech Covid-19 vaccine, following the Food and Drug Administration's (FDA) amendment to the emergency use authorizations of the vaccines. Studies suggest a booster shot for these individuals increases protection against the Covid-19 virus. The CDC has not yet provided recommendations regarding booster doses for Moderna or Johnson & Johnson (J&J) vaccine, which are likely forthcoming. For a complete list of requirements of eligibility, please visit the CDC's website at www.cdc.gov.

"Our pharmacists and pharmacy teams continue to provide vital access to Covid-19 and other vaccines in all of our communities, and we have ample vaccine supply to continue to provide first, second, and now booster Covid vaccine doses to patients based on public health guidelines," said Charlie Hartig, Chief Executive Officer, Hartig Drug Company. "With this big change, we request that everyone consider making an appointment in advance online at hartigdrug.com/appointment. Please be patient with our health care providers and pharmacists in the tri-states as we attempt to manage influenza vaccines, cough/cold and flu season, and now additional Covid-19 booster doses," he added.

Pfizer-BioNTech Covid-19 boosters will be available at every Hartig Drug location to all eligible patients regardless of where they received their first two-dose series vaccination. Hartig requests individuals bring their original Covid-19 vaccine card, a government-issued ID (optional), and prescription insurance (optional). Online appointments are encouraged at www.hartigdrug.com/appointment, but walk-ins are welcome. For further information, please get in touch with your local Hartig Drug pharmacist.

Hartig Drug continues to administer doses of Moderna, Pfizer-BioNTech, and Johnson & Johnson Covid-19 vaccines at all of its Iowa, Illinois, and Wisconsin locations and strongly encourages those who have not been vaccinated to get vaccinated. Hartig Drug also began administering flu shots last month and highly recommends individuals to receive a flu shot this fall to protect themselves and others from vaccine-preventable diseases and decrease potential hospitalizations.

###

About Hartig Drug Company
Hartig Drug Company (Hartig Drug) is a local, family-owned, and operated group of pharmacies located in the Iowa, Wisconsin, and Illinois tri-state region. Hartig Drug was founded over 115 years ago by A. J. Hartig.

Through community pharmacy, senior care (LTC) pharmacy, hospital pharmacy, and durable medical equipment locations, Hartig Drug Company is committed to providing convenient, personalized health consulting, pharmaceutical products, and consumer goods. As a local, small business Hartig Drug offers personalized services in touch with its local community roots. Our employees live, work, and play in the same communities in which we operate. The connection to the community drives us every day to provide the best possible service and products to our customers.